The efficacy of the Rességuier method in the treatment of fibromyalgia: a randomised controlled trial

Rehabilitation of fibromyalgia: efficacy of the Rességuier method - a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN62054712

Enrollment

Registered

2008-12-23

Start date

2007-01-10

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia Musculoskeletal Diseases Other soft tissue disorders, not elsewhere classified

Interventions

FMS patients were recruited and randomly assigned to the Group A and Group B. The patients of Group A were individually treated with the Rességuier method for 8 weeks, 1 session a week. The patients o

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of fibromyalgia according to the American College of Rheumatology (ACR) criteria 2. No age limits

Exclusion criteria

Exclusion criteria: Does not meet the inclusion criteria

Design outcomes

Primary

Measure	Time frame
1. Reduction of pain (Numerical Rating Scale [NRS]: 0 - 10) 2. Improvement of disability and quality of life, assessed by the 36-item Short Form (SF-36) Health Survey and Fibromyalgia Impact Questionnaire (FIQ)	—

Secondary

Measure	Time frame
1. Quality of movement (NRS: 0 - 10) 2. Ability to relax mind and body (NRS: 0 - 10)	—

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026